StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

Recruiting

Phase 1

StrataMGTStrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms

Sponsor:

Andrew T. Goldstein, MD

Code:

NCT06662942

Conditions

Vulvar Lichen Sclerosus

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

StrataMGT

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-03-03. This information was provided to ClinicalTrials.gov by Andrew T. Goldstein, MD on 2024-11-08.